Fig. 4From: RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthmaCorrelation of DEGs (log ratios, filtered by p.adj.fdr < 0.05) in SARP and UBIOPRED severe asthma samples vs. healthy controls against lung DEGs in the mouse HDM model ± RORγt inhibitor. Red shading indicates a positive correlation (r > 0) and blue shading indicates a negative correlation (r < 0). P values and R values are providedBack to article page